Elsevier

Human Pathology

Volume 27, Issue 4, April 1996, Pages 408-416
Human Pathology

Original contribution
Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor

https://doi.org/10.1016/S0046-8177(96)90115-XGet rights and content

Abstract

The identification of Ewing's sarcoma (ES) and peripheral neuroectodermal tumor (PNET) among other small round cell tumors (SRCTs) is a critical issue in musculoskeletal pathology because of the lack of clearly distinctive morphological features. In this study, the authors have compared advantages and limits of two procedures that were recently suggested as additional tools for the identification of ES/PNET, the analysis of p30/32MIC2 antigen by immunohistochemistry, and the evaluation of the fusion products of two specific chromosomal aberrations, the t(11;22)(q24;q12) and the t(21;22)(q22;ql2), by reverse transcriptase-polymerase chain reaction (RT-PCR). The authors have analyzed the expression of p30/ 32MIC2 in 28 cell lines and in 90 tumor samples. p30/32MIC2 was highly expressed in ES/PNET but was also present in all the other cell types. The broad spectrum of positivity for p30/32MIC2 in SRCTs of bone was substantially confirmed by the analysis of tissue samples. In the same material, the authors have evaluated the presence of t(11;22) or t(21;22) transcripts (EWS/FLI-1 and EWS/ERG, respectively) by RT-PCR. These transcripts were found in all the cell lines and tissue samples of ES/PNET, but not in other tumors. The authors' results question the use of p30/32MIC2 immunostaining alone for the identification of ES/PNET and suggest the adoption of RT-PCR as an advantageous alternative. Molecular diagnosis of ES/PNET by RTPCR is highly specific and can be applied to small amounts of tissue. Moreover, RNA extracted from paraffin-embedded specimens was shown to be suitable for RT-PCR analysis, thus enabling analysis of archival material.

References (39)

  • L Furezi et al.

    Cytogenetics of Askin's tumor: Case report and review of the literature

    Pathol Res Pract

    (1993)
  • M Campanacci

    Bone and Soft Tissue Tumors

  • G Bacci et al.

    Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy

    Cancer

    (1989)
  • WJ Rettig et al.

    Ewing's sarcoma: New approaches to histogenesis and molecular plasticity

    Lab Invest

    (1992)
  • SF Schlossman et al.

    CD antigens 1993

    J Immunol

    (1994)
  • G Hamilton et al.

    Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen

    Cancer Res

    (1988)
  • R Levy et al.

    A human thymus-leukaemia antigen defined by hybridoma monoclonal antibodies

  • NC Dracopoli et al.

    Genes controlling gp25/30 cell-surface molecules map to chromosomes X and Y and escape X-inactivation

    Am J Hum Genet

    (1985)
  • IM Ambros et al.

    MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors

    Cancer

    (1991)
  • Cited by (0)

    Supported by Consiglio Nazionale delle Ricerche, Progetto Finalizzato Applicazioni Cliniche Della Ricerca Oncologica, and by Istituti Ortopedici Rizzoli, Ricerca Corrente. Stefania Benini is a recipient of a fellowship from the Associazione Italiana per la Ricerca sul Cancro.

    View full text